Signature Health INC.

Signature Health INC. was paid $5.58M by Medicaid between Jan 2018 and Dec 2024, across 29 billing codes. Its largest line is G0480, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed — 38% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Ohio

Rank by total paid#22 of 116

Median peer was paid$313K

This provider vs. median18×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	103,876	$1.12M
2019	98,931	$1.36M
2020	44,372	$650K
2021	21,684	$568K
2022	13,423	$616K
2023	12,030	$677K
2024incomplete	10,014	$588K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	38%	38,429	24,479	$2.11M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	29%	51,510	26,342	$1.63M
80361		7.0%	31,904	15,652	$392K
80362		6.9%	31,532	15,421	$382K
80355		4.2%	32,801	16,121	$236K
80348		4.0%	32,336	15,728	$221K
80354		3.9%	31,885	15,618	$219K
80365		3.8%	31,658	15,528	$210K
80346		<1%	3,225	2,084	$47K
80349		<1%	6,347	3,780	$43K
80321		<1%	2,993	2,321	$28K
80324		<1%	3,219	2,017	$23K

17 more codes

80353		<1%	3,184	$22K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	109	$9K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	206	$5K
80373		<1%	455	$3K
87210		<1%	1,059	$3K
80345		<1%	134	$1K
80366		<1%	123	$915.42
81025		<1%	213	$837.19
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	91	$660.08
80305		<1%	114	$346.54
83036	Hemoglobin; glycosylated (A1C)	<1%	75	$309.05
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	28	$204.36
86703		<1%	187	$195.32
81003		<1%	145	$156.99
H0048	Alcohol and/or other drug testing: collection and handling only, specimens other than blood	<1%	334	$114.87
80368		<1%	13	$86.81
T1015	A visit at a community health center or clinic (one all-in rate)	0%	21	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialEGLESTON, INDRANI (CFO)

Same official

Other billing entities under EGLESTON, INDRANI

Full network →

Provider	Location	Paid
Signature Health INC.	Painesville, OH	$8.88M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.